These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10831269)

  • 1. Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity.
    Tran A; Longo F; Ouzan D; Bianchi D; Pradier C; Saint-Paul MC; Sattonnet C; Laffont C; Dantin S; Piche T; Benzaken S; Rampal P
    Scand J Gastroenterol; 2000 Apr; 35(4):433-7. PubMed ID: 10831269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.
    Lau DT; Kleiner DE; Ghany MG; Park Y; Schmid P; Hoofnagle JH
    Hepatology; 1998 Oct; 28(4):1121-7. PubMed ID: 9755252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients with persistently normal aminotransferase levels.
    Hasan F; Asker H; Al-Khalid J; Al-Mekhaizeem K; Al-Shamali M; Siddique I; Al-Nakib B
    Digestion; 2002; 65(2):127-30. PubMed ID: 12021486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.
    Pockros PJ; Tong M; Lee WM; van Leeuwen DJ; Keeffe EB; Bala K; Killenberg PG; Foust RT; Rosenblate HJ; Payne KM; Fromm H; Lesesne HR; Black M
    J Viral Hepat; 1998 Jul; 5(4):271-6. PubMed ID: 9751014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
    Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
    Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
    Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
    J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.
    Tassopoulos NC; Vafiadis I; Tsantoulas D; Syrokosta J; Hatzis G; Delladetsima JK; Demonakou M; Sypsa V; Hatzakis AE
    J Interferon Cytokine Res; 2002 Mar; 22(3):365-9. PubMed ID: 12034044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia.
    Shiffman ML; Hofmann CM; Contos MJ; Luketic VA; Sanyal AJ; Sterling RK; Ferreira-Gonzalez A; Mills AS; Garret C
    Gastroenterology; 1999 Nov; 117(5):1164-72. PubMed ID: 10535880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
    Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
    J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
    Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
    Hepatogastroenterology; 1999; 46(26):1094-9. PubMed ID: 10370673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C.
    Guilera M; Forns X; Torras X; Enríquez J; Coll S; Solà R; Morillas R; Planas R; Ampurdanès S; Soler M; Costa J; Sáiz JC; Sánchez-Tapias JM; Rodés J
    J Hepatol; 2000 Jul; 33(1):135-41. PubMed ID: 10905597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. The Donor Surveillance Study Group.
    Prati D; Zanella A; Zanuso F; Vianello L; Della Torre E; Mozzi F; Carriero PL; Zahm F; Donato MF; Colombo M; Sirchia G
    J Viral Hepat; 2000 Sep; 7(5):352-60. PubMed ID: 10971823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
    Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.
    Samuel D; Bizollon T; Feray C; Roche B; Ahmed SN; Lemonnier C; Cohard M; Reynes M; Chevallier M; Ducerf C; Baulieux J; Geffner M; Albrecht JK; Bismuth H; Trepo C
    Gastroenterology; 2003 Mar; 124(3):642-50. PubMed ID: 12612903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C.
    Hanrotel C; Toupance O; Lavaud S; Thiefin G; Brodard V; Ingrand D; Diebold MD; Wynckel A; Chanard J
    Nephron; 2001 Jun; 88(2):120-6. PubMed ID: 11399913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum transaminase elevations during pegylated interferon treatment of chronic HCV hepatitis probably induced by polyethylene glycol.
    Caroleo B; Gallelli L; Staltari O; De Sarro G; Guadagnino V
    Intervirology; 2008; 51(6):407-9. PubMed ID: 19258719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.